Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950138-96-000275
Filing Date
1996-09-10
Accepted
1996-09-10 00:00:00
Documents
4
Effectiveness Date
1996-09-29
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM S-8 S-8 12885
2 1996 STOCK OPTION PLAN EX-4 36227
3 OPINION OF BRYAN CAVE LLP EX-5 1811
4 CONSENT OF RICHARD A. EISNER & COMPANY, LLP EX-23.(A) 621
  Complete submission text file 0000950138-96-000275.txt   53276
Mailing Address 9000 HARRY HINES BLVD DALLAS TX 75235
Business Address 9000 HARRY HINES BLVD DALLAS TX 75235 2143532922
CYTOCLONAL PHARMACEUTICS INC /DE (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-11691 | Film No.: 96628039
SIC: 2834 Pharmaceutical Preparations